The revenue stands at ₹3,676.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.35 per cent from ₹3,080.00 crore. This corresponds to a year-on-year *(YoY) growth of 35.40 per cent.
Operating Profit stands at ₹1,566.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.78 per cent from ₹1,255.00 crore. This corresponds to a year-on-year *(YoY) growth of 76.35 per cent.
PBDT stands at ₹1,647.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.44 per cent from ₹1,313.00 crore. This corresponds to a year-on-year *(YoY) growth of 60.68 per cent.
Profit Before Tax stands at ₹1,505.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.54 per cent from ₹1,180.00 crore. This corresponds to a year-on-year *(YoY) growth of 65.02 per cent.
Net Profit stands at ₹1,127.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.94 per cent from ₹902.00 crore. This represents a 63.57 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Divi's Lab. | 0.04% | -2.92% | 22.28% | 30.39% | 60.80% | 72.24% |
| Sun Pharma.Inds. | 0.17% | -0.89% | 7.17% | -1.47% | -0.64% | 4.81% |
| Torrent Pharma. | -0.40% | -1.01% | 2.66% | -6.82% | 4.80% | 25.24% |
| Laurus Labs | 5.55% | -2.30% | 13.46% | 29.50% | 73.98% | 136.99% |
| Zydus Lifesci. | 1.15% | -0.23% | 8.06% | 8.84% | 18.03% | 29.27% |
Chairman & Independent Directo : Ramesh B V Nimmagadda
Executive Director & MD : Murali K Divi
Executive Director : N V Ramana
Executive Director / Whole Time Director / CEO : Kiran S Divi
ED / WTD - Commercial : Nilima Prasad Divi
Executive Director / Whole Time Director : S. Devendra Rao
Independent Non Exe. Director : S Ganapaty
Independent Non Exe. Director : Sunaina Singh
Independent Non Exe. Director : Kosaraju Veerayya Chowdary
Independent Non Exe. Director : Rajendrakumar Premchand Shah
Company Sec. & Compli. Officer : Satish Choudhury